Economic and Clinical Benefits of Galantamine in the Treatment of Mild to Moderate Alzheimer's Disease in a Korean Population: A 52-Week Prospective Study

To evaluate the impact of galantamine treatment on the function, caregiver time, and resource used in the treatment of patients with mild to moderate Alzheimer's disease (AD), costs and outcomes were evaluated during a 52-week prospective, randomized, double-blind, community-controlled trial of...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Guk-Hee, Jung, Hee Yeon, Lee, Chang Uk, Choi, Sungku
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526501/
https://www.ncbi.nlm.nih.gov/pubmed/18303192
http://dx.doi.org/10.3346/jkms.2008.23.1.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526501/
https://www.ncbi.nlm.nih.gov/pubmed/18303192
http://dx.doi.org/10.3346/jkms.2008.23.1.10

Ejemplares similares